Anthem Biosciences Pvt. Ltd. – Leading Contract Research & Innovation Service Provider (CRISP)
Anthem Biosciences Pvt. Ltd. is a premier Contract Research and Innovation Service Provider (CRISP) specializing in drug discovery, chemical development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs), Highly Potent APIs (HPAPIs), Nutraceuticals, Probiotics, and Enzymes. Headquartered in Bangalore, India, the company has established itself as a trusted global partner for pharmaceutical, biotechnology, and specialty chemical industries.
With state-of-the-art R&D facilities, cutting-edge manufacturing capabilities, and stringent regulatory compliance, Anthem Biosciences is recognized for its scientific excellence and innovative problem-solving approach in contract research and manufacturing.
Core Business & Expertise
Anthem Biosciences specializes in:
- Contract Research & Development – Supporting early-stage drug discovery, chemical development, and analytical services.
- Custom Manufacturing – Scaled production of APIs, HPAPIs, enzymes, and nutraceuticals.
- Biologics & Fermentation-Based Production – Developing high-value probiotics and enzymes.
- Regulatory & Compliance Services – Ensuring GMP, FDA, and global regulatory standards.
Product & Service Portfolio
1. Contract Research Services
- Drug Discovery & Development – Offering hit-to-lead and lead optimization services.
- Chemical Development & Process Optimization – Accelerating early-stage pharmaceutical development.
- Discovery Biology Services – Supporting in-vitro and in-vivo pharmacology studies.
- Analytical Development & Validation – Ensuring regulatory-compliant analytical testing.
2. Manufacturing Services
- Active Pharmaceutical Ingredients (APIs) – Custom synthesis and commercial-scale API production.
- Highly Potent APIs (HPAPIs) – Specialized facilities for oncology and cytotoxic drugs.
- Nutraceutical Ingredients – Developing probiotics, herbal extracts, and functional health supplements.
- Industrial Enzymes & Probiotics – Large-scale production of biocatalysts for food, feed, and pharmaceutical applications.
Key Strengths & Competitive Advantages
1. State-of-the-Art Research & Manufacturing Facilities
- Integrated R&D and cGMP-certified manufacturing plants spanning 350,000+ square feet.
- Custom synthesis labs equipped with high-throughput screening, process chemistry, and analytical validation capabilities.
- Dedicated high-containment HPAPI manufacturing facilities, ensuring worker safety and environmental compliance.
2. Quality, Compliance & Regulatory Approvals
Anthem Biosciences maintains the highest industry standards, holding certifications such as:
- GMP (Good Manufacturing Practices) Certified
- US FDA-Approved API Manufacturing Facilities
- ISO 9001:2015 & ISO 14001:2015 Quality Management System
- ICH Q7 & EU GMP Compliant
- Kosher & Halal Certified Nutraceuticals
3. Global Market Presence & Strategic Collaborations
Anthem Biosciences partners with leading global pharmaceutical, biotech, and specialty chemical companies, supplying to key markets:
- North America (USA, Canada)
- Europe (Germany, UK, France)
- Asia-Pacific (Japan, South Korea, Australia)
- Middle East & Emerging Markets
Export Statistics:
- Over 1,000 metric tons of APIs and specialty ingredients supplied annually.
- Preferred CRO/CDMO partner for more than 300 global biotech and pharma companies.
Financial & Market Insights
- Estimated Annual Revenue (2023): ₹800-1,000 crore (~$100-125 million USD).
- Year-over-Year Growth: 15-20% CAGR.
- Production Capacity: Over 2,000 metric tons per year.
- R&D Investment: 15% of annual revenue dedicated to drug discovery and biopharmaceutical innovations.
Customer Trust & Testimonials
- "Anthem Biosciences has been instrumental in accelerating our drug discovery programs with their top-tier contract research services. Their expertise in synthetic chemistry and process development is unmatched." – Dr. John Peterson, VP R&D, Global Pharma Corp.
- "Their GMP-certified manufacturing facilities and commitment to regulatory compliance make them a reliable partner for our API supply chain." – Michael Adams, Director of Procurement, Leading Biotech Firm
Industry Recognition & Achievements
- Recognized as "Best CRO/CDMO of the Year 2023" by the Indian Pharmaceutical Awards.
- Successfully developed multiple first-in-class specialty APIs for global pharma markets.
- Expanded biologics division with advanced fermentation-based probiotics and enzyme production.
Future Roadmap
Anthem Biosciences is focused on expanding its scientific and manufacturing capabilities through:
- Investment in AI-driven drug discovery platforms.
- Expansion of HPAPI manufacturing facilities for oncology and rare disease therapeutics.
- Increased production capacity for nutraceuticals and probiotics.
- New collaborations with biotech startups for precision medicine development.
Conclusion
Anthem Biosciences Pvt. Ltd. is a leader in contract research and manufacturing, offering end-to-end solutions for drug discovery, API manufacturing, and specialty biotech applications. With strong R&D capabilities, regulatory expertise, and global market reach, Anthem Biosciences continues to drive innovation in the pharmaceutical and life sciences industry.
